No Smoking Day March 12Th

ThinkingThinking AheadAhead Diabetes Week 8th – 14th June 2014

Diabetes Week 2014 – i Can NICE (www.nice.org.uk) Patient Information

 NICE Pathways - diabetes - includes managing type 1 and type 2 NHS Choices diabetes, and foot care for people with diabetes (Last updated May 2014)  Diabetes, Type 1, Diabetes, Type 2 - Includes information on various aspects of the different types of diabetes as well as symptoms, treatment, prevention and self  QS6: Quality Standards for diabetes in adults (March 2011) care advice  TA203:Diabetes (Type 2) - liraglutide (October 2010) Diabetes UK www.diabetes.org.uk  TA248:Diabetes (type 2) - exenatide (prolonged release) (February 2012)  UK charity providing information and support for people with diabetes, including  TA288:Dapagliflozin in combination therapy for Type 2 diabetes (June links to the Diabetes UK Tracker Smartphone App for logging levels such as blood 2013) glucose, carbohydrates and calories, and an HbA1c Converter to help with the  TA301: Fluocinolone implant for diabetic macular oedema (Nov 2013) transition from the percentage system.  CG87: Diabetes type 2 - newer agents (May 2009) – Replaces previous guidance as well as including information on newer agents for blood Juvenile Diabetes Research Foundation (JDRF) glucose control. Note 2010 & 2011 update information (current update in  UK charity providing information specifically on type 1 diabetes progress)  CG63: Diabetes in pregnancy (Updated July 2008). Guideline currently Other Useful Information being updated, expected Feb 2015 NHS Evidence NICE Clinical Knowledge Summaries (CKS)  Library of evidence including research, guidelines and information sources on Diabetes Type 1, Diabetes Type 2 & Diabetes Prevention  Diabetes type 2 - includes advice on management, as well as information on related problems including: lipids, foot problems, eye MHRA Drug Safety Update problems, neuropathy (Last revised July 2010, minor update March 2014)  Insulin degludec (Tresiba): available in additional higher strength than existing  Insulin therapy in type 2 diabetes - provides information on the use of insulins – care needed to minimise risk of error, including training for patients (April insulin for the treatment of adults with type 2 diabetes (Last revised Nov 2013) 2010, minor update July 2013)  Dipeptidylpeptidase-4 inhibitors (‘gliptins’): risk of acute pancreatitis (Sept 2012)

Produced by Nicola Watts, Medicines Information Pharmacist, Wessex Drug & Medicines Information Centre May 2014 Diabetes Week ThinkingThinking AheadAhead th th New Drugs in Diabetes 8 – 14 June 2014 Others NICE Evidence Summaries  Cochrane Review: Intensive glucose control versus conventional glucose control  Type 2 diabetes: empagliflozin (March 2014) for type 1 diabetes mellitus (Dec 2012)  Type 2 diabetes: lixisenatide (Sept 2013)  Cochrane Review: Cinnamon for diabetes mellitus - there is insufficient evidence to  Type 2 diabetes: insulin degludec (Sept 2013) support the use of cinnamon for type 1 or type 2 diabetes mellitus (Sept 2012)  Type 1 diabetes: insulin degludec (Sept 2013)  Insulin Pump Therapy - DTB 2012:50;105-8 (password required for full text)  Type 2 diabetes: alogliptin (May 2013)  UKMi Q&A 367: When is self-monitoring of blood glucose recommended in type 2 Drug & Therapeutics Bulletin (password required for full text) diabetes? (Apr 2013)  Dapagliflozin (Forxiga) for type 2 diabetes? (2013)  Insulin degludec for diabetes mellitus (2013)

Produced by Nicola Watts, Medicines Information Pharmacist, Wessex Drug & Medicines Information Centre May 2014